Prot #EZH-1201: A Phase I, Open-Label Multi-Dose Pharmacokinetic and Safety Study of Oral Tazemetostat in Subjects With Moderate And Severe Hepatic Impairment With Advanced Malignancies

Project: Research project

Project Details

StatusActive
Effective start/end date7/8/207/8/23

Funding

  • Pharmaceutical Research Associates, Inc. (Prot #EZH-1201)
  • Epizyme, Inc. (Prot #EZH-1201)